Woburn, MA – According to filings with the U.S. Securities and Exchange Commission, OSSIO is raising $38,500,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Brian Verrier played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About OSSIO
Ossio is an orthopedic medical device company founded in Israel in 2014 with the vision to completely transform the orthopedic experience for physicians, patients, and payors. Ossios mission is to replace metal implants as the standard of care in the $10B+ orthopedic fixation market (screws, pins, plates) with an intelligent bone regeneration technology. OSSIOfiber represents a breakthrough material platform for orthopedic and podiatric surgeons who seek a more biologically friendly way to restore mobility with nothing permanent left behind. Our products have the mechanical strength needed for easy insertion and secure fixation while enabling the body to regrow bone, completely incorporating and replacing the implant without the adverse inflammation and weakness often seen in bio-resorbables.

To learn more about OSSIO, visit http://www.ossio.io/

Contact:
Brian Verrier, Chief Executive Officer
833-781-7373

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved